Microgel Coating Gives Donor Cells a Boost in Reversing Pulmonary Fibrosis
Research shows it may be possible to reverse fibrosis and promote tissue repair through treatment with microgel-coated mesenchymal stromal cells.
Category: Cystic fibrosis
Cystic fibrosis
Latest
Cystic fibrosis
Latest
The Future of CRISPR for Cystic Fibrosis Just Got a Boost
The National Institutes of Health is funding a grant of more than $2 million to adapt tools that may increase the accuracy of CRISPR gene editing for cystic fibrosis.
Cystic fibrosis
Latest
How Bacteria Can Defeat Drugs That Fight Cystic Fibrosis
Scientists have conducted new research into how bacteria defeat antibiotics in infections that are commonly seen in cystic fibrosis patients.
Medical AI Company Thirona Obtains License For Cystic Fibrosis Lung Scan Tech
The AI medical image analysis company received a license to develop an AI tool to analyze lung scans for cystic fibrosis (CF).
Read More
Cystic Fibrosis: FDA Approves Kalydeco For Infants as Young as 4 Months
The US FDA has approved Kalydeco (ivacaftor, Vertex Pharma) as a therapy for cystic fibrosis in infants as young as 4 months old to less than 6 months old.
Read More
FDA Grants Pediatric Disease Designations to Spirovant’s New Cystic Fibrosis Therapy
Spirovant Sciences announced that the FDA has granted Orphan Drug and Rare Pediatric Disease Designations to its lead product candidate, SPIRO-2101, for cystic fibrosis treatment.
Read More
Bioengineered Lung Sheds Light on Cystic Fibrosis Progression
Researchers at the University of Michigan have created a 3D bioengineered model of lung tissue to better understand cystic fibrosis and potential treatments.
Read More
Treating Cystic Fibrosis With Concomitant Azithromycin and Tobramycin
New research shows that cystic fibrosis patients who had pulmonary exacerbations treated with concomitant azithromycin and tobramycin had worse outcomes than those treated with tobramycin alone.
Read More
How Has COVID-19 Affected Therapy Adherence in Cystic Fibrosis Patients?
Clinicians say a combination of factors have led to improved therapy adherence and disease management in young cystic fibrosis patients since the outset of the novel coronavirus pandemic.
Read More
How Does Age Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis
Age may impact outcomes in lung transplant recipients with cystic fibrosis, a new study shows.
Read More
Cystic Fibrosis Drug Kaftrio Will Become Available on NHS
The drug, Kaftrio, produced by Vertex Pharmaceuticals, will be available through the NHS to many who have cystic fibrosis.
Read More
Novel Cystic Fibrosis Drug KB407 Granted Orphan Drug Designation
Krystal Biotech Inc’s KB407 is an inhaled, repeat-dose gene therapy for cystic fibrosis currently in the preclinical phase.
Read More
Cystic Fibrosis: Phase 1B Trial Begins for Arginase Inhibitor
Calithera Biosciences Inc has dosed the first patients in its Phase 1b clinical trial of the arginase inhibitor CB-280 in adult patients with cystic fibrosis and chronic airway infection.
Read More
Scientists Build Computer Model to Understand the Genetics of Cystic Fibrosis
Researchers at the University of Virginia School of Engineering and other across the country are working on a computer model to understand which genes cause cystic fibrosis and other diseases.
Read More
Protein at the Root of Cystic Fibrosis Infections
Swiss researchers highlight how the protein Vav3 creates bacterial docking stations to facilitate lung infections in cystic fibrosis.
Read More